Effect of canagliflozin use on body weight and blood pressure at one-year follow-up: A systematic review and meta-analysis

Eur J Prev Cardiol. 2019 Oct;26(15):1680-1682. doi: 10.1177/2047487319829940. Epub 2019 Feb 12.

Authors

Muhammad Shahzeb Khan¹, Muhammad Shariq Usman², Tariq Jamal Siddiqi², Muhammad Mustafa Memon², Sanjiv J Shah³, Sadiya S Khan³

Affiliations

¹ Internal Medicine, John H Stroger Jr Hospital of Cook County, Chicago, IL, USA.
² Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
³ Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

PMID: 30755019
DOI: 10.1177/2047487319829940

No abstract available

Publication types

Letter
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review

MeSH terms

Blood Pressure / drug effects*
Canagliflozin / adverse effects
Canagliflozin / therapeutic use*
Diabetes Mellitus, Type 2 / diagnosis
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / physiopathology
Humans
Sodium-Glucose Transporter 2 Inhibitors / adverse effects
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*
Time Factors
Treatment Outcome
Weight Loss / drug effects*

Substances

Sodium-Glucose Transporter 2 Inhibitors
Canagliflozin